wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28067411-230913FD-98CA-40BC-931E-FE6DC350A35C
Q28067411-230913FD-98CA-40BC-931E-FE6DC350A35C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067411-230913FD-98CA-40BC-931E-FE6DC350A35C
Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need
P2860
Q28067411-230913FD-98CA-40BC-931E-FE6DC350A35C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28067411-230913FD-98CA-40BC-931E-FE6DC350A35C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d884531518b10a7b4707c8030d4ab802d9376c5
P2860
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study.